ODDB.org: Open Drug Database

Teva Pharma AG - Irinotecan-Teva liquid 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	59217	Sequence	04
Product name	Irinotecan-Teva liquid 300 mg/15 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description	Irinotecan
Introduction of Sequence	26.07.2011

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 1.294 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300mg / 15ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

Inactive agents	Dose
Acidum (S)-lacticum
Acidum Hydrochloridum ad Ph
Natrii Hydroxidum ad Ph
Sorbitol	675mg / 15ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
007		245.64	283.55	A	SL	No

2025	©ywesee GmbH